← Scroll for more →
Aurinia Pharmaceuticals Inc. (AUPH)
Pharmaceutical Preparations
Latest Price
$16.20
TTM P/E
7.10
Normalized P/E
70.57
Div Yield
--
Book Value
4.78
P/B Ratio
3.39
Valuation metrics
adjust assumptions →EPS: $2.07
Book value / share: $4.39
Formula: √(22.5 × EPS × BVPS)
Graham Number
$14.30
12% downside
Base FCF: $90M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$51.09
+215% upside
EPS: $2.07
Target P/E: 71×
Formula: EPS × P/E
P/E Fair Value
$146.97
+808% upside
Institutional Ownership
59.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 13.04M | $221.0M | 9.81% | +814.6K | 2026-06-30 |
| BlackRock, Inc. | 8.19M | $139.0M | 6.16% | +347.6K | 2026-06-30 |
| Goldman Sachs Group Inc | 5.62M | $95.0M | 4.23% | +4.19M | 2026-06-30 |
| NEA Management Company, LLC | 3.97M | $67.0M | 2.99% | -- | 2026-06-30 |
| Two Sigma Investments, LP | 3.47M | $58.0M | 2.61% | -- | 2026-06-30 |
| Arrowstreet Capital, Limited Partnership | 3.26M | $55.0M | 2.46% | -20.3K | 2026-06-30 |
| State Street Corp | 2.59M | $43.0M | 1.95% | +62.5K | 2026-06-30 |
| Morgan Stanley | 2.31M | $39.0M | 1.74% | +75.7K | 2026-06-30 |
| Marshall Wace, LLP | 2.04M | $34.0M | 1.54% | +169.4K | 2026-06-30 |
| Geode Capital Management, LLC | 1.70M | $28.0M | 1.28% | +165.1K | 2026-06-30 |